Is it safe to take hydroxyzine, bupropion (Wellbutrin), and duloxetine together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, this combination can be taken together, but requires careful monitoring for specific drug interactions and side effects.

The combination of hydroxyzine, bupropion (Wellbutrin), and duloxetine is commonly used in clinical practice and can be safe, but requires attention to seizure risk, potential drug-drug interactions through CYP2D6 inhibition, and monitoring for CNS side effects.

Key Drug Interaction Concerns

CYP2D6 Inhibition - The Primary Issue

Both bupropion and duloxetine are moderate inhibitors of CYP2D6 12. When combined, this creates a cumulative inhibitory effect that can:

  • Increase plasma levels of drugs metabolized by CYP2D6
  • Potentially elevate hydroxybupropion levels (bupropion's active metabolite)
  • Theoretically increase dopaminergic effects

One case report documented delirium in an elderly patient when bupropion was added to duloxetine, attributed to elevated hydroxybupropion levels causing excessive dopamine elevation 3. This resolved within 3 days of stopping bupropion.

Seizure Threshold Lowering

The FDA label explicitly warns that bupropion should be used with "extreme caution" when combined with other antidepressants that lower seizure threshold 11. Both duloxetine and bupropion can lower seizure threshold, requiring:

  • Use of low initial doses with gradual titration
  • Avoidance in patients with seizure history, eating disorders, or abrupt alcohol/benzodiazepine discontinuation
  • Monitoring for factors that further lower threshold (sleep deprivation, stimulants, other medications)

Hydroxyzine Considerations

Hydroxyzine has minimal pharmacokinetic interactions with this combination. However:

  • QT prolongation risk: Hydroxyzine can prolong QT interval 4, though this is dose-dependent and clinically significant primarily at higher doses
  • Additive CNS effects: May cause increased sedation, though this can be therapeutically beneficial for anxiety/insomnia
  • One animal study showed no additional benefit of combining duloxetine with hydroxyzine for anxiety 5, but this doesn't indicate safety concerns

Clinical Evidence for the Combination

Duloxetine + Bupropion Efficacy

Multiple studies support using duloxetine and bupropion together for treatment-resistant depression:

  • A retrospective chart review of 10 patients showed significant improvement (CGI scores decreased from 4.4 to 2.1, p<0.0001) with 60% response rate and 30% remission rate 6
  • Side effects were manageable: nausea, dry mouth, jitteriness/agitation, fatigue (each in 2 patients), with no life-threatening events
  • A randomized controlled trial showed modest efficacy but noted higher atypical features predicted non-response 7

Practical Management Algorithm

Before Starting the Combination:

  1. Screen for seizure risk factors:

    • History of seizures, head trauma, CNS tumor
    • Eating disorders (anorexia/bulimia)
    • Abrupt benzodiazepine or alcohol discontinuation
    • Medications that lower seizure threshold
  2. Obtain baseline ECG if:

    • Age >60 years
    • Cardiac history
    • Using hydroxyzine doses >50 mg/day
    • Other QT-prolonging medications present
  3. Check for CYP2D6 substrate medications:

    • Type 1C antiarrhythmics (flecainide, propafenone) - narrow therapeutic index, high risk 4
    • Beta-blockers (metoprolol)
    • Other antipsychotics (haloperidol, risperidone, thioridazine)

Dosing Strategy:

  • Start low, go slow with bupropion (begin 150 mg XL daily, not immediate release)
  • Duloxetine: Standard dosing 30-60 mg daily
  • Hydroxyzine: Keep ≤50 mg/day to minimize QT risk; use primarily as needed rather than standing doses

Monitoring Schedule:

Weeks 1-2:

  • Weekly contact for suicidality screening (FDA black box warning for all antidepressants) 8
  • Assess for agitation, restlessness, tremor, insomnia

Weeks 4-8:

  • Evaluate therapeutic response
  • Monitor for CNS toxicity: confusion, delirium (especially in elderly), excessive stimulation
  • Check blood pressure (both drugs can increase BP)

Ongoing:

  • If adding any new CYP2D6 substrates, consider dose reduction of the substrate medication
  • Minimize alcohol use (bupropion warning) 1

Specific Populations Requiring Extra Caution

Elderly Patients:

  • Higher delirium risk with the duloxetine-bupropion combination 3
  • Start with lower doses (bupropion 100 mg SR, duloxetine 20-30 mg)
  • More frequent monitoring for confusion, falls, orthostatic hypotension

Cardiac Patients:

  • Avoid if on flecainide or other Type 1C antiarrhythmics without cardiology consultation 4
  • Monitor ECG if using hydroxyzine regularly
  • Both duloxetine and bupropion can increase blood pressure

When to Avoid This Combination

Absolute contraindications:

  • Current seizure disorder or history of seizures
  • Concurrent MAOI use (14-day washout required) 11
  • Eating disorders (anorexia nervosa, bulimia)
  • Abrupt benzodiazepine/alcohol discontinuation

Relative contraindications requiring specialist consultation:

  • Congenital long QT syndrome
  • Taking Type 1C antiarrhythmics
  • Severe hepatic impairment
  • Uncontrolled hypertension

Bottom Line

This three-drug combination is used successfully in clinical practice, particularly for treatment-resistant depression with comorbid anxiety. The main risks—seizures, CYP2D6 interactions, and CNS overstimulation—are manageable with appropriate patient selection, gradual dose titration, and systematic monitoring. Start with low doses of bupropion (150 mg XL), use standard duloxetine dosing, keep hydroxyzine as needed rather than standing, and monitor closely in the first 2-4 weeks 16.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.